Kainos Medicine Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
19
About the Report
About the Report
Summary
Kainos Medicine Inc (Kainos) is a drug discovery and development company that develops drugs and medicines for cancer, brain disease, metabolic and infectious diseases. The company offers antiviral drugs, Parkinson's drugs, HIV drugs, anticancer drugs and HBV medications. Its anticancer drugs include DNMT inhibitor(KM101), EZH2 inhibitor(KM301), and BRD4 inhibitor(KM601). Kainos' Parkinson's drugs comprise Dopamine supplement therapy (Levodopa), Dopaminergic agonist (Ropinirole), COMT inhibitor (Tolcapone) and MAO-B inhibitor (Selegiline). The company provides anticancer drug for leukemia. It also develops novel drug candidates and conducts preclinical and early clinical studies. The company has operations in Seongnam and Daejeon, South Korea. Kainos is headquartered in Seongnam, South Korea.
Kainos Medicine Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kainos Medicine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kainos Medicine Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kainos Medicine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kainos Medicine Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Kainos Medicine Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Kainos Medicine Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Kainos Medicine Enters into Agreement with Institut Pasteur Korea 10
Jiangsu Aidea Enters Agreement with Kainos Medicine 11
Kainos Medicine Enters into Co-Development Agreement with Hanmi Pharm 12
Kainos Medicine Enters into Research Agreement with Korea University 13
Licensing Agreements 14
Kainos Medicine Enters into Licensing Agreement with KRICT 14
Kainos Medicine Inc-Key Competitors 15
Kainos Medicine Inc-Key Employees 16
Kainos Medicine Inc-Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Clinical Trials 18
Jan 27, 2017: Kainos Medicine Announces Initiation of Phase 1 Clinical Study of KM-819 in the Treatment of Parkinson's Disease 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19
List of Figure
List of Figures
Kainos Medicine Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Kainos Medicine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Kainos Medicine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Kainos Medicine Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Kainos Medicine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kainos Medicine Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Kainos Medicine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kainos Medicine Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List of Table
List of Tables
Kainos Medicine Inc, Pharmaceuticals & Healthcare, Key Facts 2
Kainos Medicine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kainos Medicine Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kainos Medicine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kainos Medicine Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Kainos Medicine Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Kainos Medicine Enters into Agreement with Institut Pasteur Korea 10
Jiangsu Aidea Enters Agreement with Kainos Medicine 11
Kainos Medicine Enters into Co-Development Agreement with Hanmi Pharm 12
Kainos Medicine Enters into Research Agreement with Korea University 13
Kainos Medicine Enters into Licensing Agreement with KRICT 14
Kainos Medicine Inc, Key Competitors 15
Kainos Medicine Inc, Key Employees 16
Kainos Medicine Inc, Other Locations 17
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.